Randomized trial on the therapeutic equivalence between Eprex and GerEPO in patients on haemodialysis

Treatment of renal anaemia with epoetin is well established. However, epoetin is expensive. Biogeneric epoetin with proven efficacy would reduce cost and improve access to therapy. We conducted this first ever comparative study of a biogeneric and the original product.